Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Dogwood Therapeutics, Inc. (VIRI) filed a Form S-8 to register 108,612 additional shares of common stock for issuance under its Amended and Restated 2020 Equity Incentive Plan. The new shares supplement prior S-8 registrations (Dec 21 2020 and Jun 22 2022) and follow Board authorization on Apr 17 2025 and shareholder approval on Jun 18 2025. Standard incorporation-by-reference, exhibits (legal opinion, auditor consent, plan document) and undertakings are included. The filing is an administrative step to ensure sufficient shares are available for employee equity awards and does not provide new financial results or strategic disclosures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many Virios Therapeutics (VIRI) SEC filings are available on StockTitan?
StockTitan tracks 17 SEC filings for Virios Therapeutics (VIRI), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for Virios Therapeutics (VIRI)?
The most recent SEC filing for Virios Therapeutics (VIRI) was filed on July 1, 2025.